Embodiments of the present invention generally relate to novel methods for
the treatment and/or prevention of neurological symptoms caused by an
avian reovirus, enteric reovirus strain (ERS), and associated
characteristics. Other embodiments generally comprise an immunogenic
composition or vaccine comprising an ERS for the treatment and/or
prevention of neurological symptoms.